Online Database of Chemicals from Around the World

2-Hydroxy-3-bromo-4-methylpyridine
[CAS# 18368-59-7]

List of Suppliers
Novasyn Organics Pvt. Ltd. India Inquire  
+91 (406) 620-2233
633-9111
info@novasynorganics.com
Chemical manufacturer
chemBlink standard supplier since 2010
Jiangsu Mingchem Corporation China Inquire  
+86 (519) 8517-0101
8517-0202
8517-0303
+86 18900654321
sales@mingchem.com
QQ chat
Chemical manufacturer since 2012
chemBlink standard supplier since 2015
Amadis Chemical Co., Ltd. China Inquire  
+86 (571) 8992-5085
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink standard supplier since 2015
Complete supplier list of 2-Hydroxy-3-bromo-4-methylpyridine
Identification
Classification Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyridine compound >> Hydroxypyridine
Name 2-Hydroxy-3-bromo-4-methylpyridine
Synonyms 3-Bromo-2-hydroxy-4-picoline; 2-Hydroxy-3-bromo-4-picoline
Molecular Structure CAS # 18368-59-7, 2-Hydroxy-3-bromo-4-methylpyridine, 3-Bromo-2-hydroxy-4-picoline, 2-Hydroxy-3-bromo-4-picoline
Molecular Formula C6H6BrNO
Molecular Weight 188.02
CAS Registry Number 18368-59-7
EC Number 869-629-3
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin irritationSkin Irrit.2H315
Acute toxicityAcute Tox.4H302
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2H319
Eye irritationEye Irrit.2AH319
SDS Available
Market Analysis Reports
List of Reports Available for 2-Hydroxy-3-bromo-4-methylpyridine
Related Products
(11bS)-4-Hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (11bS)-4-Hydroxy-2,6-bis(2,4,6-tricyclohexylphenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (11bR)-4-Hydroxy-2,6-bis(2,4,6-tricyclohexylphenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  N-Hydroxy-3,5-bis(trifluoromethyl)benzenecarboximidamide  2-Hydroxy-alpha,alpha-bis(trifluoromethyl)cyclopentanemethanol  (11bS)-4-Hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (11bR)-4-Hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide  6-Hydroxybromantane  2-Hydroxy-5-bromopyridine  1'-Hydroxybufuralol  Hydroxybupropione  5-Hydroxybuspirone  3-Hydroxybutanal  (2S)-2-Hydroxybutanedioic acid compd. with 2-amino-2-methyl-N-[(1R)-2-[(4S,5R)-2-methyl-1-oxo-4-phenyl-2,7-diazaspiro[4.5]dec-7-yl]-2-oxo-1-[(phenylmethoxy)methyl]ethyl]propanamide (1:?)  (2R)-2-hydroxy-Butanedioic acid compd. with (2R)-(2R)-2-(2,5-difluorophenyl)pyrrolidine (1:1)  (2S)-2-Hydroxybutanedioic acid compd. with (alphaR)-N,alpha-dimethyl-3,5-bis(trifluoromethyl)benzenemethanamine  (R)-3-Hydroxybutanenitrile  (S)-3-Hydroxybutanenitrile